Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Long-Term Extension Study of Vosoritide to Treat Children With HypochondroplasiaEnrolling By Invitation
NCT07073014Phase 3Updated Sep 9, 2026
Sponsor: BioMarin Pharmaceutical
Hypochondroplasia
United States, Australia, Canada, France, Germany +4 more
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsRecruiting
NCT07166601Phase 1Updated Sep 9, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumor
United States, Canada, Japan
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerActive Not Recruiting
NCT04351555Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Austria, Brazil, Bulgaria, Canada +20 more
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)Recruiting
NCT06780137Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Cancer
United States, Argentina, Australia, Chile, China +7 more
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
NCT07282665Phase 3Updated Sep 9, 2026
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)Recruiting
NCT05582993Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Von Willebrand Disease (VWD)
United States, France, Ireland, Italy, Japan +1 more
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantNot Yet Recruiting
NCT07613359Phase 2Updated Sep 9, 2026
Sponsor: Takeda
Antibody-Mediated Rejection (AMR)
United States, China, France, Germany, Japan
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)Recruiting
NCT07700056Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Pruritus of Unknown Origin
United States, Japan
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRecruiting
NCT06671496Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Psoriatic Arthritis
United States, Argentina, Australia, Brazil, Canada +7 more
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruiting
NCT07441642Phase 2Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Colombia +11 more
A Phase 1 Trial of GEN1119 in Participants With Solid TumorsRecruiting
NCT07695831Phase 1Updated Sep 9, 2026
Sponsor: Genmab
Solid Tumours
France, Japan, Spain
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Recruiting
NCT05519085Phase 3Updated Sep 9, 2026
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisRecruiting
NCT06470048Phase 2Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
United States, Argentina, Austria, Belgium, Brazil +20 more
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusRecruiting
NCT07662213Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Bulgaria +10 more
Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseActive Not Recruiting
NCT06450197Phase 2Updated Sep 9, 2026
Sponsor: AstraZeneca
Moderate to Severe Crohn's Disease
United States, Argentina, Australia, Belgium, Brazil +21 more
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque PsoriasisRecruiting
NCT07039110N/AUpdated Sep 9, 2026
Sponsor: AbbVie
Plaque Psoriasis
Canada, Czechia, France, Germany, Greece +3 more
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Active Not Recruiting
NCT04958265Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Atypical Hemolytic Uremic Syndrome
United States, Belgium, Brazil, Canada, China +5 more
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.Recruiting
NCT07753993Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Argentina, Australia, Brazil, Bulgaria +32 more
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackActive Not Recruiting
NCT06118281Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Acute Myocardial Infarction (AMI)
United States, Argentina, Australia, Brazil, Bulgaria +19 more
A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)Recruiting
NCT07646860Phase 2Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
Japan
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia ARecruiting
NCT07416526Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Argentina, Brazil, Denmark, France +10 more
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Recruiting
NCT07431281Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)Recruiting
NCT06716606Phase 3Updated Sep 9, 2026
Sponsor: GlaxoSmithKline
Connective Tissue Diseases
United States, Argentina, Australia, China, France +6 more
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental VitiligoRecruiting
NCT07431177Phase 2Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Non-segmental Vitiligo
United States, Argentina, Australia, Canada, China +7 more
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsActive Not Recruiting
NCT04083781Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Haemophilia A With Inhibitors · Haemophilia B With Inhibitors
United States, Algeria, Australia, Austria, Bulgaria +24 more

Previous page Next page